Search
forResearch 10 of 1000+
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Profound bradycardia after addition of diltiazem to a beta blocker.
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
Community 3 of 4
- Oral v topical Min & Dutasteride
- Day 1 v 3 month progress. Topical Spray used in the UK.
- Is 0.1%w/v topical fin overkill if taking oral 0.5mg fin?
Learn
— no results
Try a deeper search in learn →